The impact of hepatitis viruses on chronic lymphoproliferative disorders; preliminary results
2010

Impact of Hepatitis Viruses on Chronic Lymphoproliferative Disorders

Sample size: 41 publication Evidence: moderate

Author Information

Author(s): Vladareanu AM, Ciufu C, Neagu AM, Onisai M, Bumbea H, Vintilescu AM, Dobrea C, Arama V, Mihailescu R, Arama S

Primary Institution: University Emergency Hospital Bucharest

Hypothesis

The study aims to analyze the influence of hepatitis viral infections on chronic lymphoproliferative disorders.

Conclusion

There is a strong association between B-cell chronic lymphoproliferative disorders and hepatitis viral infections, particularly HCV.

Supporting Evidence

  • 60.97% of the patients were female.
  • 34.14% of patients had HBV infection.
  • 58.53% of patients had HCV infection.
  • 46.34% of patients had an aggressive type of chronic lymphoproliferative disorder.
  • 92.68% of patients had hepatomegaly.
  • 70.73% of patients had superficial or profound adenopathies.
  • 80.48% of patients had lymphocytosis.
  • 29.26% of patients received antiviral therapy.

Takeaway

This study looked at patients with blood disorders and found that many of them also had hepatitis infections, which can affect their health.

Methodology

Patients were diagnosed and monitored for chronic lymphoproliferative disorders and hepatitis infections using various clinical and laboratory tests.

Participant Demographics

The group consisted of 41 patients, with 60.97% females and 39.02% males, aged between 20 and 85 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication